Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35348
NL-OMON35348
Completed
Not Applicable

CoCo in COPD treatment: evaluation of use, satisfaction and clinical effects - CoCo COPD

Revalidatiecentrum Het Roessingh0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Obstructive Pulmonary DiseaseCOPD10006436

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Revalidatiecentrum Het Roessingh
Enrollment
30
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Revalidatiecentrum Het Roessingh

Eligibility Criteria

Inclusion Criteria

  • •\- a clinical diagnosis of COPD according to the GOLD criteria
  • •\- no exacerbation in the month prior to enrolment
  • •\- \>\=3 exacerbations or one hospitalization for respiratory problmens in the two years preceeding study entry
  • •\- (ex)smoker
  • •\- age\>40 years
  • •\- post\-bronchodilator FEV1 25\-80% of predicted
  • •\- able to understand and read Dutch
  • •\- internet access at home

Exclusion Criteria

  • •\- serious other disease with a low survival rate
  • •\-other diseases influencing bronchial symptoms and/or lung function (e.g. cardiac insuficiency, sarcoidosis)
  • •\- severe psychiatric illness
  • •\- uncontrolled diabetes mellitus during a COPD exacerbation in the past or a hospitalization for diabetes mellitus in the two year preceding the study
  • •\- need for regular oxygen therapy (\>16 h per day or pO2\<7\.2 kPa)
  • •\- maintenance therapy with antibiotics
  • •\- known alpha1\-antitrypsine deficiency
  • •\- disorders or progressive disease seriously influencing daily activities (e.g. amputation, paralysis, progressive muscle disease)
  • •\- impaired hand function causing inability to use application

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
CoCo in COPD treatment: Evaluation of use, satisfaction and clinical effects.
NL-OMON21635Roessingh Research and Development30
Completed
Phase 3
Study in Patients With COPDCOPD
NCT00215449Dey690
Active, not recruiting
Phase 1
The effect of reduced corticosteroid therapy in patients with acute exacerbation of COPD1) Whether a reduction of the dose systemic corticosteroids (SC) therapy in patients with acute exacerbation of COPD(AE-COPD) - compared with AE-COPD patients in the standard treatment- leading to non-inferiority 2)Whether there is a difference in treatment response in AE-COPD patients with eosinophilic airway inflammation compared to AE-COPD patients with non-eosinophilic airway inflammation 3) whether a lower accumulated dose SC may be associated with fewer corticosteroid adverse eventsMedDRA version: 20.0 Level: LLT Classification code 10010953 Term: COPD exacerbation System Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2015-003441-26-DKChronic Obstructive Pulmonary Disease Trial Network (COP:TRIN)320
Completed
Not Applicable
The effect of standard treatments in COPD patients without maintenance therapy.COPD
JPRN-UMIN000005188Tokyo Medical University100
Completed
Not Applicable
COPD Assessment in PracticeCOPD
JPRN-UMIN000012592Third department of Internal Medicine, Wakayama Medical University1,400